I think people will be surprised at the progress the company has made over the past year. I think Peak and Nico management have done well to bring the product to this level of maturity and haven’t rushed to do an IPO. Personally, I don’t mind even if they hold off and do the ipo at the end of the year once they have started off / completed a few more trials in target jurisdictions . That’s the last missing piece . Beauty of the Nico software and target market is that for clinical trials- they don’t need to waste time and money recruiting patients and then proceed. It can be done restrospectively as hospitals already have MRI scans on their database, all that needs to be done is apply the AI software and prove that it is as or more accurate that the diagnosis that was made related to the scan.
